Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Gender Differences in Case Volume Among Ophthalmology Residents.

Gong D, Winn BJ, Beal CJ, Blomquist PH, Chen RW, Culican SM, Dagi Glass LR, Domeracki GF, Goshe JM, Jones JK, Khouri AS, Legault GL, Martin TJ, Mitchell KT, Naseri A, Oetting TA, Olson JH, Pettey JH, Reinoso MA, Reynolds AL, Siatkowski RM, SooHoo JR, Sun G, Syed MF, Tao JP, Taravati P, WuDunn D, Al-Aswad LA.

JAMA Ophthalmol. 2019 Jul 18. doi: 10.1001/jamaophthalmol.2019.2427. [Epub ahead of print]

PMID:
31318390
2.

The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond - a report.

Stuttgen V, Giffney HE, Anandan A, Alabdali A, Twarog C, Belhout SA, O Loughlin M, Podhorska L, Delaney C, Geoghegan N, Mc-Fadden J, Alhadhrami NA, Fleming A, Phadke S, Yadav R, Fattah S, McCartney F, Alsharif SA, McCaul J, Singh K, Erikandath S, O Meara F, Wychowaniec JK, Cutrona MB, MacMaster G, Reynolds AL, Gaines S, Hogg B, Farrelly M, D Alton M, Coulahan P, Bhattacharjee S.

Nanotoxicology. 2019 Aug;13(6):717-732. doi: 10.1080/17435390.2019.1621402. Epub 2019 Jun 20.

PMID:
31111769
3.

Pharmacological restoration of visual function in a zebrafish model of von-Hippel Lindau disease.

Ward R, Ali Z, Slater K, Reynolds AL, Jensen LD, Kennedy BN.

Dev Biol. 2019 Feb 27. pii: S0012-1606(18)30731-0. doi: 10.1016/j.ydbio.2019.02.008. [Epub ahead of print]

PMID:
30825427
4.

Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma.

Buckley AM, Dunne MR, Lynam-Lennon N, Kennedy SA, Cannon A, Reynolds AL, Maher SG, Reynolds JV, Kennedy BN, O'Sullivan J.

Cancer Lett. 2019 Apr 10;447:115-129. doi: 10.1016/j.canlet.2019.01.009. Epub 2019 Jan 19.

PMID:
30664962
5.

The effect of oral statin therapy on strabismus in patients with thyroid eye disease.

Reynolds AL, Del Monte MA, Archer SM.

J AAPOS. 2018 Oct;22(5):340-343. doi: 10.1016/j.jaapos.2018.04.009. Epub 2018 Aug 1.

PMID:
30075294
6.

Brain-Derived Neurotrophic Factor as a Treatment Option for Retinal Degeneration.

Daly C, Ward R, Reynolds AL, Galvin O, Collery RF, Kennedy BN.

Adv Exp Med Biol. 2018;1074:465-471. doi: 10.1007/978-3-319-75402-4_57. Review.

PMID:
29721977
7.

A Brain-Derived Neurotrophic Factor Mimetic Is Sufficient to Restore Cone Photoreceptor Visual Function in an Inherited Blindness Model.

Daly C, Shine L, Heffernan T, Deeti S, Reynolds AL, O'Connor JJ, Dillon ET, Duffy DJ, Kolch W, Cagney G, Kennedy BN.

Sci Rep. 2017 Sep 12;7(1):11320. doi: 10.1038/s41598-017-11513-5.

8.

A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.

Butler CT, Reynolds AL, Tosetto M, Dillon ET, Guiry PJ, Cagney G, O'Sullivan J, Kennedy BN.

J Biol Chem. 2017 Mar 3;292(9):3552-3567. doi: 10.1074/jbc.M116.747766. Epub 2016 Dec 29.

9.

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer.

Murphy AG, Casey R, Maguire A, Tosetto M, Butler CT, Conroy E, Reynolds AL, Sheahan K, O'Donoghue D, Gallagher WM, Fennelly D, Kennedy BN, O'Sullivan J.

Sci Rep. 2016 Oct 14;6:34523. doi: 10.1038/srep34523.

10.

A sustained release formulation of novel quininib-hyaluronan microneedles inhibits angiogenesis and retinal vascular permeability in vivo.

Galvin O, Srivastava A, Carroll O, Kulkarni R, Dykes S, Vickers S, Dickinson K, Reynolds AL, Kilty C, Redmond G, Jones R, Cheetham S, Pandit A, Kennedy BN.

J Control Release. 2016 Jul 10;233:198-207. doi: 10.1016/j.jconrel.2016.04.004. Epub 2016 Apr 13.

PMID:
27086168
11.

Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis.

Reynolds AL, Alvarez Y, Sasore T, Waghorne N, Butler CT, Kilty C, Smith AJ, McVicar C, Wong VH, Galvin O, Merrigan S, Osman J, Grebnev G, Sjölander A, Stitt AW, Kennedy BN.

J Biol Chem. 2016 Apr 1;291(14):7242-55. doi: 10.1074/jbc.M115.710665. Epub 2016 Feb 4.

12.

MLL3 and MLL4 Methyltransferases Bind to the MAFA and MAFB Transcription Factors to Regulate Islet β-Cell Function.

Scoville DW, Cyphert HA, Liao L, Xu J, Reynolds A, Guo S, Stein R.

Diabetes. 2015 Nov;64(11):3772-83. doi: 10.2337/db15-0281. Epub 2015 Jul 15.

13.

Back to the beginning for the Eighth Evacuation Hospital in Morocco during World War II 70 years ago.

Reynolds HY, Reynolds AL, Vogel LL.

Trans Am Clin Climatol Assoc. 2014;125:154-69; discussion 170. No abstract available.

14.

Targeting the PI3K/Akt/mTOR pathway in ocular neovascularization.

Sasore T, Reynolds AL, Kennedy BN.

Adv Exp Med Biol. 2014;801:805-11. doi: 10.1007/978-1-4614-3209-8_101. Review.

PMID:
24664774
15.

Current and emerging therapies for ocular neovascularisation.

Reynolds AL, Kent D, Kennedy BN.

Adv Exp Med Biol. 2014;801:797-804. doi: 10.1007/978-1-4614-3209-8_100. Review.

PMID:
24664773
16.

The genetics of outer segment morphogenesis in zebrafish.

Reynolds AL, Blacque OE, Kennedy BN.

Adv Exp Med Biol. 2012;723:431-41. doi: 10.1007/978-1-4614-0631-0_55. Review. No abstract available.

PMID:
22183362
17.

Race-related stress, racial identity status attitudes, and emotional reactions of Black Americans.

Carter RT, Reynolds AL.

Cultur Divers Ethnic Minor Psychol. 2011 Apr;17(2):156-62. doi: 10.1037/a0023358.

PMID:
21604839
18.

Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy.

Alvarez Y, Chen K, Reynolds AL, Waghorne N, O'Connor JJ, Kennedy BN.

Dis Model Mech. 2010 Mar-Apr;3(3-4):236-45. doi: 10.1242/dmm.003772. Epub 2010 Feb 8.

19.

Selective inhibition of retinal angiogenesis by targeting PI3 kinase.

Alvarez Y, Astudillo O, Jensen L, Reynolds AL, Waghorne N, Brazil DP, Cao Y, O'Connor JJ, Kennedy BN.

PLoS One. 2009 Nov 17;4(11):e7867. doi: 10.1371/journal.pone.0007867.

20.

Telehealth applications in speech-language pathology: a modified narrative review.

Reynolds AL, Vick JL, Haak NJ.

J Telemed Telecare. 2009;15(6):310-6. doi: 10.1258/jtt.2009.081215. Review.

PMID:
19720769
21.

Influence of a quantitative trait locus on mouse chromosome 19 to the light-adapted electroretinogram.

Reynolds AL, Danciger M, Farrar GJ, Humphries P, Kenna PF.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4058-63. doi: 10.1167/iovs.07-1620. Epub 2008 Mar 14.

PMID:
18344449
22.

Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism.

Fang WB, Ireton RC, Zhuang G, Takahashi T, Reynolds A, Chen J.

J Cell Sci. 2008 Feb 1;121(Pt 3):358-68. doi: 10.1242/jcs.017145. Epub 2008 Jan 15.

23.

Variation in the electroretinogram of C57BL/6 substrains of mouse.

Reynolds AL, Farrar GJ, Humphries P, Kenna PF.

Adv Exp Med Biol. 2008;613:383-91. doi: 10.1007/978-0-387-74904-4_45. No abstract available.

PMID:
18188968
24.

Perspectives on creating multicultural campuses.

Reynolds AL, Pope RL.

J Am Coll Health. 1994 Mar;42(5):229-33. Review. No abstract available.

PMID:
8201137
25.

Nifedipine as a second line antihypertensive drug in pregnancy.

Constantine G, Beevers DG, Reynolds AL, Luesley DM.

Br J Obstet Gynaecol. 1987 Dec;94(12):1136-42.

PMID:
3426985
26.

Medical memoranda. Toxic effect of podophyllum application in pregnancy.

Chamberlain MJ, Reynolds AL, Yeoman WB.

Br Med J. 1972 Aug 12;3(5823):391-2. No abstract available.

27.

Community action in nursing education.

GORE HJ, REYNOLDS AL, ROBERTS ER.

Am J Nurs. 1957 Nov;57(11):1458-9. No abstract available.

PMID:
13478616

Supplemental Content

Loading ...
Support Center